lobbying_activities: 2300052

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2300052	64ec0074-e5ea-4046-b9d5-148b3d507cc8	Q2	RED+BLUE STRATEGIES	400693064	PEW CHARITABLE TRUSTS	2019	second_quarter	PHA	H.R. 2482 - The Mainstreaming Addition Treatment Act of 2019 - Support for policies increasing the ability to access MAT to treat addiction. H.R. 3443 - The OTC Monograph Safety Innovation and Reform Act of 2019 - Support for policies that enable OTC monograph reform. Issues related to the implementation on the SUPPORT Act (P.L. 115-271) regarding MAT treatment. Issues related to curbing antibiotic resistance.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2019-07-08T20:37:45.253000-04:00